Efficacy and safety of shorter multidrug-resistant or rifampicin-resistant tuberculosis regimens: a network meta-analysis

Abstract Background Drug-resistant tuberculosis (DR-TB) remains a threat to public health. Shorter regimens have been proposed as potentially valuable treatments for multidrug or rifampicin resistant tuberculosis (MDR/RR-TB). We undertook a systematic review and network meta-analysis to evaluate the...

Full description

Bibliographic Details

Published in:	BMC Infectious Diseases
Main Authors:	Yishak Abraham, Dawit Getachew Assefa, Tesfahunegn Hailemariam, Desye Gebrie, Dejene Tolossa Debela, Simon Tsegaye Geleta, Dagmawit Tesfaye, Michele Joseph, Tsegahun Manyazewal
Format:	Article
Language:	English
Published:	BMC 2024-10-01
Subjects:	Rifampicin-resistant tuberculosis (RR-TB) Multidrug-resistant tuberculosis (MDR-TB) Short- term regimens Systematic review Network meta-analysis
Online Access:	https://doi.org/10.1186/s12879-024-09960-3